NSCLC · Decision Support
1
Welcome
2
Your Diagnosis
3
Your Results
4
Your Preferences
Summary
PharmASSIST
Non-Small Cell Lung Cancer
Help your care team give you
the best possible cancer treatment
This survey helps start the conversation with your care team about your diagnosis, your testing, and your treatment preferences.
~40%
of NSCLC patients don't receive comprehensive biomarker testing before treatment
5.6×
increase in treatment preparedness with Shared Decision-Making
5 min
to complete these questions
Print or share your summary with your care team at your next appointment.
Decision Support. Better Care.
Question 1 of 8
Were you told you have non-small cell lung cancer (NSCLC)?
This includes adenocarcinoma, squamous cell, and large cell lung cancer.
Yes — I was told I have NSCLC
No — I was told I have a different type
I'm not sure
Question 2 of 8
Has your cancer spread beyond the lung?
Yes — it has spread to other parts of my body
Your doctor may have called this metastatic or stage IV
No — it appears to be in the lung only
I'm not sure
Question 3 of 8
Did you have surgery to remove your lung tumor?
Yes
No
I'm not sure
Question 4 of 8
Have you started any treatment yet?
No — I have not started treatment
Yes — I have started treatment
I'm not sure
Question 5 of 8
Has your tumor been tested for biomarkers or genetic changes?
Sometimes called molecular tests, NGS, or tumor profiling.
Yes — results are back
Yes — waiting for results
No — I don't think this was ordered
I'm not sure
Question 7 of 8
Is there someone who helps you make important medical decisions?
Yes — a family member or partner
Yes — a caregiver or healthcare proxy
No — I make decisions on my own
I'd like help identifying someone
Question 8 of 8
Do you have someone who can help you with appointments, medications, or daily activities during treatment?
Yes — I have reliable support
Sometimes — support is limited or not always available
No — I will be managing mostly on my own
Question 9 of 11
Did your doctor tell you whether any mutations or changes were found in your tumor?
Yes — something was found
No — nothing was found
Results were unclear or incomplete
I haven't discussed results with my doctor yet
Question 10 of 11
Do you know the name of what was found?
It is completely okay if you don't know.
EGFR
ALK
KRAS G12C
ROS1, RET, MET, or NTRK
PD-L1 only — no other mutation found
Something was found but I don't know the name
Not sure
Question 11 of 11
Would you like more time or information before making a treatment decision?
Yes — I'd like more time to talk with my care team first
No — I feel ready to discuss my options
I'm not sure yet
Question 12 of 15
Did your doctor tell you the specific type of EGFR mutation?
Common EGFR mutation
Your doctor may have said exon 19, exon 21, or L858R
Exon 20 insertion
A different or uncommon type
I know it's EGFR but don't know the type
I'm not sure
Question 13 of 15
Has the cancer spread to your brain or spine?
Yes
No
I'm not sure
Question 14 of 15
Are you concerned about the cost of your cancer medications?
Yes
Somewhat
No
Question 15 of 15
How important are each of the following to you?
Select one answer for each item. Your answers go directly to your care team.
Key: E = Extremely important V = Very important S = Somewhat important NP = Not a priority
EVSNP
Is there anything else you'd like your care team to know?
Optional — your words will appear directly in your summary.
Has your doctor talked with you about what treatment they are recommending?
Yes — we have a treatment plan
We talked but I didn't fully understand
Not yet
Would you like more time to talk with your care team before making a decision?
Yes — I'd like more time first
No — I feel ready
Your summary is ready
Print it or bring this screen to your next appointment.
🩺 Clinician Summary — PharmASSIST
PharmASSIST
PharmASSIST — Patient-Reported Summary · NSCLC
Patient Overview
Treatment Preferences
For educational and decision-support purposes only. Does not replace clinical judgment.